124 related articles for article (PubMed ID: 10357881)
21. Adhesive and/or signaling functions of CD44 isoforms in human dendritic cells.
Haegel-Kronenberger H; de la Salle H; Bohbot A; Oberling F; Cazenave JP; Hanau D
J Immunol; 1998 Oct; 161(8):3902-11. PubMed ID: 9780156
[TBL] [Abstract][Full Text] [Related]
22. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines.
Stewart JP; Behm FG; Arrand JR; Rooney CM
Virology; 1994 May; 200(2):724-32. PubMed ID: 8178456
[TBL] [Abstract][Full Text] [Related]
24. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
25. Identification of two regions in the cytoplasmic domain of CD44 through which PMA, calcium, and foskolin differentially regulate the binding of CD44 to hyaluronic acid.
Liu D; Liu T; Sy MS
Cell Immunol; 1998 Dec; 190(2):132-40. PubMed ID: 9878114
[TBL] [Abstract][Full Text] [Related]
26. Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain.
Liu D; Sy MS
J Immunol; 1997 Sep; 159(6):2702-11. PubMed ID: 9300690
[TBL] [Abstract][Full Text] [Related]
27. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
English NM; Lesley JF; Hyman R
Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
[TBL] [Abstract][Full Text] [Related]
28. The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.
Steel CM; Morten JE; Foster E
IARC Sci Publ; 1985; (60):265-92. PubMed ID: 2998993
[TBL] [Abstract][Full Text] [Related]
29. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
Hu LF; Chen F; Altiok E; Winberg G; Klein G; Ernberg I
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():248-60. PubMed ID: 10895161
[TBL] [Abstract][Full Text] [Related]
30. Enhanced apoptosis mediates inhibition of EBV-transformed lymphoblastoid cell line proliferation by curcumin.
Ranjan D; Johnston TD; Reddy KS; Wu G; Bondada S; Chen C
J Surg Res; 1999 Nov; 87(1):1-5. PubMed ID: 10527697
[TBL] [Abstract][Full Text] [Related]
31. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
[TBL] [Abstract][Full Text] [Related]
32. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
33. Combination of mutant EL-4 thymoma cells and EBV-infection in B lymphocyte activation a) EBV-infection of EL-4-activated lymphocytes. b) Use of EL-4 cells as feeders for lymphoblastoid cell lines.
Barcellini W; Borghi MO; Nicoletti F; Bonara P; Fain C; Meroni PL
J Clin Lab Immunol; 1990 Sep; 33(1):21-8. PubMed ID: 1966941
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction.
Kitagawa N; Goto M; Kurozumi K; Maruo S; Fukayama M; Naoe T; Yasukawa M; Hino K; Suzuki T; Todo S; Takada K
EMBO J; 2000 Dec; 19(24):6742-50. PubMed ID: 11118209
[TBL] [Abstract][Full Text] [Related]
35. Phenylbutyrate induces cell differentiation and modulates Epstein-Barr virus gene expression in Burkitt's lymphoma cells.
Bar-Ner M; Thibault A; Tsokos M; Magrath IT; Samid D
Clin Cancer Res; 1999 Jun; 5(6):1509-16. PubMed ID: 10389940
[TBL] [Abstract][Full Text] [Related]
36. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
[TBL] [Abstract][Full Text] [Related]
37. Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion.
Turley EA; Austen L; Moore D; Hoare K
Exp Cell Res; 1993 Aug; 207(2):277-82. PubMed ID: 7688314
[TBL] [Abstract][Full Text] [Related]
38. Interleukins 4 and 13 upregulate expression of cd44 in human colonic epithelial cell lines.
Trejdosiewicz LK; Morton R; Yang Y; Banks RE; Selby PJ; Southgate J
Cytokine; 1998 Oct; 10(10):756-65. PubMed ID: 9811528
[TBL] [Abstract][Full Text] [Related]
39. Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus.
Blazar BA; Sutton LM; Strome M
Cancer Res; 1983 Oct; 43(10):4562-8. PubMed ID: 6309371
[TBL] [Abstract][Full Text] [Related]
40. Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells.
Fagard R; Mouas H; Dusanter-Fourt I; Devillers C; Bissières P; Martin A; Lenoir G; VanTan H; Feuillard J; Raphaël M
Oncogene; 2002 Jul; 21(29):4473-80. PubMed ID: 12085225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]